Wan X, Wang L, Khan MA, Peng L, Sun X, Yi X, Wang Z, Chen K (2025). NAT10-mediated N4-acetylcytidine modification in KLF9 mRNA promotes adipogenesis. Cell Death & Differentiation. Online published. https://doi.org/10.1038/s41418-025-01483-x. Cite Score: 24.7; Journal Quartile: Q1; ISI Impact factor: 13.7.

Wang Z, Wan X, Khan MA , Peng L , Sun X , Yi X, Chen K (2024). NAT10 promotes liver lipogenesis in mouse through N4-acetylcytidine modification of Srebf1 and Scap mRNA. Lipids in Health and Disease. 23:368. https://doi.org/10.1186/s12944-024-02360-1. Cite Score: 7.7; Journal Quartile: Q1; ISI Impact Factor: 3.9

Wan X, Wang L, Khan MA, Peng L, Zhang K, Sun X, Yi X, Wang Z, Chen K (2024). Shift work promotes adipogenesis via cortisol-dependent downregulation of EGR3-HDAC6 pathway. Cell Death Discovery. 10: 129. https://doi.org/10.1038/s41420-024-01904-9. Cite Score: 8.3; Journal Quartile: Q1; ISI Impact Factor: 6.1

Yi X, Wan XX, Khan MA, Sun X, Wang Z, Chen K, Peng L (2024). Expression analysis of circRNAs in human adipogenesis. Diabetes Metabolic Syndrome and Obesity. 17: 45-54. https://doi.org/10.2147/dmso.s381603. Cite Score: 5.9; Journal Quartile: Q2; ISI Impact Factor: 2.8

Khan MA, Tania M (2023). Cordycepin and kinase inhibition in cancer. Drug Discovery Today. 28(3):103481. https://doi.org/10.1016/j.drudis.2022.103481. Cite Score: 14.8; Journal Quartile: Q1; ISI Impact factor: 6.5

Liu J, Wan XX, Zheng SY, He HH, Khan MA, Feng YX, Xiao JG, Chen Y, Hu XM, Zhang Q, Xiong K (2024). Mesenchymal Stem Cell Transplantation in Type 1 Diabetes Treatment: Current Advances and Future Opportunity. Current Stem Cell Research and Therapy. 19(9):1175-1184. https://doi.org/10.2174/011574888x268740231002054459. Cite Score: 4.2; Journal Quartile: Q2; ISI Impact Factor: 2.1

Sun X, Wan X, Khan MA, Zhang K, Yi X, Wang Z, Chen K (2023). Comprehensive analysis of circRNA expression profiles in Human Brown Adipose Tissue. Diabetes Metabolic Syndrome and Obesity. 16:469-478. https://doi.org/10.2147/dmso.s398620. Cite Score: 5.9; Journal Quartile: Q2; ISI Impact Factor: 2.8

He YF, Hu XM, Khan MA, Yu BY, Sheng YC, Xiao XZ, Wan XX, Tan SP, Xiong K (2023). HSF1 Alleviates Brain Injury by Inhibiting NLRP3-Induced Pyroptosis in a Sepsis Model. Mediators of Inflammation. 2023:2252255. https://doi.org/10.1155/2023/2252255. Cite Score: 8.7; Journal Quartile: Q2; ISI Impact Factor: 4.4

Akter Z, Khan FZ, Khan MA* (2023). Gold nanoparticles in triple-negative breast cancer therapeutics. Current Medicinal Chemistry. 30(3): 316-334. https://doi.org/10.2174/0929867328666210902141257. Cite Score: 8.6; Journal Quartile: Q1; ISI Impact Factor: 3.5

Khan MA, Zheng M, Fu J, Tania M, Li J, Fu J (2022). Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro. BMC Cancer. 22:707. https://doi.org/10.1186/s12885-022-09782-z. Cite Score: 6.0; Journal Quartile: Q2; ISI Impact Factor: 3.4

Zheng M, Mei Z, Junaid M, Tania M, Fu J, Chen H, Khan MA* (2022). Synergistic role of thymoquinone on anticancer activity of 5-fluorouracil in triple negative breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry. 22(6):1111-1118. https://doi.org/10.2174/1871520621666210624111613. Cite Score: 5.1; Journal Quartile: Q3; ISI Impact Factor: 2.6

Wei C, Khan MA (equal contributor), Du J, Cheng J, Tania M, Leung E, Fu J (2022). Cordycepin inhibits triple-negative breast cancer cell migration and invasion by regulating EMT-TFs SLUG, TWIST1, SNAIL1 and ZEB1. Frontiers in Oncology. 12:898583. https://doi.org/10.3389/fonc.2022.898583. Cite Score: 6.2; Journal Quartile: Q2; ISI Impact Factor: 3.5.

Shariare MH, Khan MA, Al-Masum A, Khan JH, Uddin J, Kazi M (2022). Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines. Molecules. 27(19):6744. https://doi.org/10.3390/molecules27196744. Cite Score: 7.4; Journal Quartile: Q1; ISI Impact Factor: 4.2

Imani S, Becatti M, Khan MA* (2022). Molecular Targeted Therapy in Oncology: Lessons from Pharmacogenetics and Pharmacoepigenetics. Frontiers in Molecular Biosciences. 9:822188. https://pubmed.ncbi.nlm.nih.gov/35372509/. Cite Score: 7.2; Journal Quartile: Q1; ISI Impact Factor: 3.9

Afroz R, Tanvir EM, Tania M, Fu J, Kamal MA, Khan MA* (2022). LPS/TLR4 pathways in breast cancer: insights into cell signaling. Current Medicinal Chemistry. 29(13):2274-2289. https://doi.org/10.2174/0929867328666210811145043. Cite Score: 8.6; Journal Quartile: Q1; ISI Impact Factor: 3.5

Wan XX, Zhang DY, Khan MA, Zheng SY, Hu XM, Zhang Q, Yang RH, Xiong K (2022). Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta Cells Replacement. Frontiers in Endocrinology. 13: 859638. https://doi.org/10.3389/fendo.2022.859638. Cite Score: 5.7; Journal Quartile: Q1; ISI Impact Factor: 3.9

Nyamsambuu A, Khan MA, Zhou X, Chen H (2022). Molecular mechanism of inhibitory effects of melatonin on prostate cancer cell proliferation, migration and invasion. Plos One. 17(1): e0261341. https://doi.org/10.1371/journal.pone.0261341. Cite Score: 6.2; Journal Quartile: Q1; ISI Impact Factor: 2.9

Zhang K , Wan X, Khan MA , Sun X, Yi X, Wang Z, Chen K, Peng L (2022). Peripheral Blood circRNA Microarray Profiling Identities hsa_circ_0001831 and hsa_circ_0000867 as Two Novel circRNA Biomarkers for Early Type 2 Diabetic Nephropathy. Diabetes Metabolic Syndrome and Obesity. 15: 2789-2801. https://doi.org/10.2147/dmso.s384054. Cite Score: 5.9; Journal Quartile: Q2; ISI Impact Factor: 2.8

Nyamsambuu A, Zhou X, Khan MA, Ahmed A, Naranmandakh S, Fu J, Chen H (2022). Anti-Oxidant and Anticancerous Effect of Fomitopsis officinalis (Vill. ex Fr. Bond. et Sing) Mushroom on Hepatocellular Carcinoma Cells In Vitro through NF-kB Pathway. Anti-Cancer Agents in Medicinal Chemistry. 22(8):1561-1570. https://doi.org/10.2174/1871520621666210608101152. Cite Score: 5.1; Journal Quartile: Q3; ISI Impact Factor: 2.6

Babu G, Bin Islam S, Khan MA* (2022). A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh. Molecular Biology Reports. 49: 6725-6739. https://doi.org/10.1007/s11033-022-07282-8. Cite Score: 5.0; Journal Quartile: Q2; ISI Impact Factor: 2.6

Tuli HS, Mistry H, Kaur G, Aggarwal D, Garg VK, Mittal S, Yerer MB, Sak K, Khan MA (2022). Gallic acid: a dietary polyphenol that exhibits anti-neoplastic activities by modulating multiple oncogenic targets. Anti-Cancer Agents in Medicinal Chemistry. 22(3):499-514. https://doi.org/10.2174/1871520621666211119085834. Cite Score: 5.1; Journal Quartile: Q3; ISI Impact Factor: 2.6

Islam MS, Morshed R, Babu G, Khan MA* (2022). The role of inflammations and EMT in carcinogenesis. Advances in Cancer Biology – Metastasis. 5:100055. https://doi.org/10.1016/j.adcanc.2022.100055. Cite Score: 2.4; Journal Quartile: Q4; ISI Impact factor: 2.0

Khan MA*, Bin Islam S, Rakib MU, Alam D, Hossen MM, Tania M, Asad A (2022). Major drugs used in COVID-19 treatment: molecular mechanisms, validation and current progress in trials. Coronaviruses. 3(2): e030821188723. http://dx.doi.org/10.2174/2666796701999201204122819. Cite Score: 1.5; Journal Quartile: Q4

Khan MA, Kamal MA (2021). Targeting cellular signaling pathways in cancer by natural compounds (editorial). Current Medicinal Chemistry. 28(39): 7986-7. https://doi.org/10.2174/092986732839211221230307. Cite Score: 8.6; Journal Quartile: Q1; ISI Impact Factor: 3.5

Tuli HS, Joshi R, Aggarwal, D, Kaur G, Kaur J, Kumar M, Parashar NC, Khan MA, Sak K (2021). Molecular mechanisms underlying chemopreventive potential of butein: current trends and future perspectives. Chemico-Biological Interactions. 350: 109699. https://doi.org/10.1016/j.cbi.2021.109699. Cite Score: 7.7; Journal Quartile: Q1; ISI Impact factor: 4.7

Nyamsambuu A, Ahmed A, Khusbu FY, Oidovsambuu S, Khan MA, Zhou X, Fu J, Chen H (2021). Anti-oxidant and Antiproliferative Activities of Mongolian Medicinal Plant Extracts and Structure Isolation of Gnetin - H Compound. Medicinal Chemistry. 17(9): 963-973. https://doi.org/10.2174/1573406416666201106110117. Cite Score: 4.3; Journal Quartile: Q3; ISI Impact factor: 1.9

Tania M, Asad A, Li T, Islam MS, Bin Islam S, Hossen MM, Bhuiyan MR, Khan MA* (2021). Thymoquinone against infectious diseases: perspectives in recent pandemics and future therapeutics. Iranian Journal of Basic Medical Sciences. 2021; 24(8): 1014-1022. https://doi.org/10.22038/ijbms.2021.56250.12548. Cite Score: 4.0; Journal Quartile: Q3; ISI Impact Factor: 2.1

Ali MY, Akter Z, Mei Z, Zheng M, Tania M, Khan MA* (2021). Thymoquinone in autoimmune diseases: therapeutic potential and molecular mechanisms. Biomedicine & Pharmacotherapy. 134: 111157. https://doi.org/10.1016/j.biopha.2020.111157. Cite Score: 11.9; Journal Quartile: Q1; ISI Impact Factor: 6.9

Akter Z, Ahmed FR, Tania M, Khan MA* (2021). Targeting inflammatory mediators: An anticancer mechanism of thymoquinone action. Current Medicinal Chemistry. 28(1): 80-92. https://doi.org/10.2174/0929867326666191011143642. Cite Score: 8.6; Journal Quartile: Q1; ISI Impact Factor: 3.5

Junaid M, Akter Y, Afrose SS, Tania M, Khan MA* (2021). Biological role of AKT, and regulation of AKT signaling pathway by thymoquinone: perspectives in cancer therapeutics. Mini-Reviews in Medicinal Chemistry. 21(3): 288-301. https://doi.org/10.2174/1389557520666201005143818. Cite Score: 7.8; Journal Quartile: Q2; ISI Impact Factor: 3.3

Afrose SS, Junaid M, Akter Y, Tania M, Zheng M, Khan MA* (2020). Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics. Drug Discovery Today. 25(12): 2294-2306. https://doi.org/10.1016/j.drudis.2020.07.019. Cite Score: 14.8; Journal Quartile: Q1; ISI Impact factor: 6.5

Shawon J, Akter Z, Hossen MM, Akter Y, Sayeed A, Junaid M, Afrose S, Khan MA* (2020). Current landscape of natural products against coronaviruses: perspectives in COVID-19 treatment and antiviral mechanism. Current Pharmaceutical Design. 26(41): 5241-5260. https://doi.org/10.2174/1381612826666201106093912. Cite Score: 6.3; Journal Quartile: Q2; ISI Impact Factor: 2.6

Fu J, Cheng J, Wei C, Khan MA, Jin Z, Fu J (2020). Assessing 23 Y‑STR loci mutation rates in Chinese Han father–son pairs from southwestern China. Molecular Biology Reports. 47(10):7755-7760. https://doi.org/10.1007/s11033-020-05851-3. Cite Score: 5.0; Journal Quartile: Q2; ISI Impact Factor: 2.6

Zhang L, Zhou Q, Cheng J, Khan MA, Fu J, Duan C, Sun S, Lv H, Fu J (2020). Targeted next-generation sequencing identified novel compound heterozygous variants in the CDH23 gene causing Usher syndrome type ID in a Chinese patient. Frontiers in Genetics. 11:422. https://doi.org/10.3389/fgene.2020.00422. Cite Score: 5.5; Journal Quartile: Q2; ISI Impact Factor: 2.8

Khan MA*, Tania M (2020). Cordycepin in Anticancer Research: Molecular Mechanism of Therapeutic Effects. Current Medicinal Chemistry. 27(6): 983-996. https://doi.org/10.2174/0929867325666181001105749. Cite Score: 8.6; Journal Quartile: Q1; ISI Impact Factor: 3.5

Agarwal V, Tuli HS, Thakral F, Singhal P, Agarwal D, Srivastava S, Pandey A, Sak K, Varol M, Khan MA, Sethi G (2020). Molecular mechanisms of action of Hesperidin in cancer: recent trends and advancements. Experimental Biology and Medicine. 245(5):486-497. https://doi.org/10.1177/1535370220903671. Cite Score: 6.0; Journal Quartile: Q2; ISI Impact Factor: 2.8

Cheng J, Peng J, Fu J, Khan MA, Tan P, Wei C, Deng X, Chen H, Fu J (2020). Identification of a novel germline BRCA2 variant in a Chinese breast cancer family. Journal of Cellular and Molecular Medicine. 24.1676–1683. https://doi.org/10.1111/jcmm.14861. Cite Score: 11.5; Journal Quartile: Q2; ISI Impact Factor: 4.3

Fu J, Cheng J, Zhou Q, Khan MA, Duan C, Peng J, Lv H, Fu J (2020). Novel compound heterozygous nonsense variants, p.L150* and p.Y3565*, of the USH2A gene in a Chinese pedigree are associated with Usher syndrome type IIA. Molecular Medicine Reports. 22. 3464-3472. https://doi.org/10.3892/mmr.2020.11400. Cite Score: 7.6; Journal Quartile: Q2; ISI Impact Factor: 3.4

Liu X, Cheng J, Mei Z, Wei C, Khan MA, Peng J, Fu J (2020). SCAR marker for identifcation and discrimination of specifc medicinal Lycium chinense Miller from Lycium species from ramp‑PCR RAPD fragments. 3 Biotech. 10(8):334. https://doi.org/10.1007/s13205-020-02325-y. Journal Quartile: Q2; ISI Impact Factor: 2.6

Khan MA, Tania M, Fu J (2019). Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics. Drug Discovery Today. 24(12):2315-2322. https://doi.org/10.1016/j.drudis.2019.09.007. Cite Score: 14.8; Journal Quartile: Q1; ISI Impact factor: 6.5

Chen Q, Liu J, Zhuang Y, Bai L, Yuan Q, Zheng S, Liao K, Khan MA, Wu Q, Luo C, Liu L, Wang H, Li T (2019). Identification of an IKKβ inhibitor for inhibition of inflammation in vivo and in vitro. Pharmacological Research. 149:104440. https://doi.org/10.1016/j.phrs.2019.104440. Cite Score: 18.7; Journal Quartile: Q1; ISI Impact factor: 9.1

Agarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MA, Sethi G (2019). Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules. 9(11):735. https://doi.org/10.3390/biom9110735. Cite Score: 9.4; Journal Quartile: Q1; ISI Impact factor: 4.8

Tania M, Shawon J, Saif K, Kiefer R, Safaei Khorram M, Halim MA, Khan MA* (2019). Cordycepin downregulates Cdk-2 to interfere with cell cycle and increases apoptosis by generating ROS in cervical cancer cells: in vitro and in silico study. Current Cancer Drug Targets. 19(2): 152-159. https://doi.org/10.2174/1568009618666180905095356. Cite Score: 5.4; Journal Quartile: Q2; ISI Impact Factor: 2.3

Zhou B, Wei C, Khan MA, Chen H, Fu J (2019). Characterization and molecular cloning of novel isoforms of human spermatogenesis associated gene SPATA3. Molecular Biology Reports. 46(4):3827-3834. https://doi.org/10.1007/s11033-019-04825-4. Cite Score: 5.0; Journal Quartile: Q2; ISI Impact Factor: 2.6

Islam MT, Zhou ZX, Chen F, Khan MA, Fu J, Chen H (2019). Targeting the Signalling Pathways Regulated by Deubiquitinases for Prostate Cancer Therapeutics. Cell Biochemistry and Function. 37(5): 304-319. https://doi.org/10.1002/cbf.3401. Cite Score: 6.2; Journal Quartile: Q2; ISI Impact Factor: 2.8

Cheng J, Fu J, Zhou Q, Xiang X, Wei C, Yang L, Khan MA, Lv H, Fu J (2019). A novel splicing mutation in the PRPH2 gene causes autosomal dominant retinitis pigmentosa in a Chinese pedigree. Journal of Cellular and Molecular Medicine. 23: 3776–3780. https://doi.org/10.1111/jcmm.14278. Cite Score: 11.5; Journal Quartile: Q2; ISI Impact Factor: 4.3

Khanh TT, Lee RJ, Kilmartin PA, Khan MA, Safei Khorram M, Tamm T, Kiefer R (2018). Actuation increase in polypyrrole bilayer by photo-activated dopants. Synthetic Metals. 246:57-63. https://doi.org/10.1016/j.synthmet.2018.10.001. Cite Score: 8.3; Journal Quartile: Q1; ISI Impact Factor: 4.0

Safei Khorram M, Fatemi A, Khan MA, Kiefer R, Jafarnia S (2018). Potential risk of weed outbreak by increasing biochar’s application rates in slow-growth legume, Lentil (Lens culinaris Medik.). Journal of the Science of Food and Agriculture. 98(6):2080-2088. https://doi.org/10.1002/jsfa.8689. Cite Score: 8.1; Journal Quartile: Q1; ISI Impact Factor: 3.3

Yang L, Ijaz I, Cheng J, Wei C, Tan X, Khan MA, Fu X, Fu J (2018). Evaluation of amplification refractory mutation system (ARMS) technique for quick and accurate prenatal gene diagnosis of CHM variant in choroideremia. Application of Clinical Genetics. 11:1-8. https://doi.org/10.2147/tacg.s144383. Cite Score: 5.4; Journal Quartile: Q2; ISI Impact Factor: 2.6

Khan MA, Tania M, Fu S, Fu J (2017). Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. 8(31): 51907-51919. https://doi.org/10.18632/oncotarget.17206. Cite Score: 6.6; Journal Quartile: Q2; ISI Impact Factor: 5.16 (IF of 2017; then dropped)

Li J, Khan MA (equal contribution), Wei C, Cheng J, Chen H, Yang L, Ijaz I, Fu J (2017). Thymoquinone inhibits the migration and invasive characteristics of cervical cancer cells SiHa and CaSki in vitro by targeting epithelial to mesenchymal transition associated transcription factors Twist1 and Zeb1. Molecules. 22(12): 2105. https://doi.org/10.3390/molecules22122105. Cite Score: 7.4; Journal Quartile: Q1; ISI Impact Factor: 4.2

Imani S, Wei C, Cheng J, Khan MA (equal contribution), Fu S, Yang L, Tania M, Zhang X, Xiao X, Zhang X, Fu J (2017). MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-‎TFs)‎ and inhibits breast cancer cell migration and invasion. Oncotarget. 8(13):21362-21379. https://doi.org/10.18632/oncotarget.15214. Cite Score: 6.6; Journal Quartile: Q2; ISI Impact Factor: 5.16 (IF of 2017; then dropped)

Cheng J, Fu S, Wei C, Tania M, Khan MA, Imani S, Zhou B, Chen H, Xiao X, Wu J, Fu J (2017). Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China. Cancer Biomarkers. 19(1):85-92. https://doi.org/10.3233/cbm-160380. Cite Score: 5.2; Journal Quartile: Q2; ISI Impact Factor: 2.2

Mei Z, Zhang X, Khan MA, Imani S, Liu X, Zou H, Wei C, Fu J (2017). Genetic analysis of Penthorum chinense Pursh. By improved-RAPD and ISSR in China. Electronic Journal of Biotechnology. 30: 6-11. https://doi.org/10.1016/j.ejbt.2017.08.008. Cite Score: 5.6; Journal Quartile: Q3; ISI Impact Factor: 2.3

Mei Z, Khan MA, Zhang X, Fu J (2017). Rapid and accurate genetic authentication of Penthorum chinense by improved RAPD-derived species-specific SCAR markers. Biodiversitas. 18(3):1243-1249. https://doi.org/10.13057/biodiv/d180349. Cite Score: 2.8; Journal Quartile: Q2;

Khan MA, Cheng JL, Mei ZQ, Wei CL, Fu JJ (2016). Development of two novel specific SCAR markers by cloning improved RAPD fragments from the medicinal mushroom Ganoderma lucidium (Leysser: Fr) Karst. Genetics and molecular research. 15(3): gmr.15038536. https://doi.org/10.4238/gmr.15038536. Cite Score: 1.0; Journal Quartile: Q4; ISI Impact Factor: 0.6

Wei C, Cheng J, Zhou B, Zhu L, Khan MA, He T, Zhou S, He J, Lu S, Chen H, Zhang D, Zhao Y, Fu J (2016). Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein. Scientific Reports. 6: 29822. https://doi.org/10.1038/srep29822. Cite Score:7.5; Journal Quartile: Q1; ISI Impact Factor: 3.8

Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J (2015). Thymoquinone inhibits Cancer metastasis by regulating TWIST1 associated with epithelial to mesenchymal transitions. Oncotarget. 6(23): 19580-19591. https://doi.org/10.18632/oncotarget.3973. Cite Score: 6.6; Journal Quartile: Q2; ISI Impact Factor: 5.16 (IF of 2017; then dropped)

Khan MA, Zhu L, Tania M, Xiao X, Fu J (2015). The relationship between SPOP mutation and breast cancer in Chinese populations. Genetics and Molecular Research. 14(4):12362-12366. https://doi.org/10.4238/2015.october.16.2. Cite Score: 1.0; Journal Quartile: Q4; ISI Impact Factor: 0.6

Liu X, Khan MA, Wei C, Cheng J, Zhang L, Fu J (2015). Establishment of stable cell line for inducing KAP1 protein expression. Acta Biologica Hungarica. 66(2): 161-168. https://doi.org/10.1556/018.66.2015.2.3. Cite Score: 3.5; Journal Quartile: Q2; ISI Impact Factor: 1.8

Mei Z, Zhang C, Khan MA, Zhu Y, Tania M, Luo P, Fu J (2015). Efficiency of improved RAPD and ISSR markers in assessing genetic diversity and relationships for Angelica sinensis (Oliv.) Diels varieties from China. Electronic Journal of Biotechnology. 18(2): 96-102. https://doi.org/10.1016/j.ejbt.2014.12.006. Cite Score: 5.6; Journal Quartile: Q3; ISI Impact Factor: 2.3

Long Y, Cheng J, Mei Z, Zhao L, Wei C, Fu S, Khan MA, Fu J (2015). Genetic analysis of litchi (Litchi chinensis Sonn.) in southern China by improved random amplified polymorphic DNA (RAPD) and inter-simple sequence repeat (ISSR). Molecular Biology Reports. 42(1): 159-166. https://doi.org/10.1007/s11033-014-3755-8. Cite Score: 5.0; Journal Quartile: Q2; ISI Impact Factor: 2.6

Cheng J, Long Y, Khan MA, Wei C, Fu S, Fu J (2015). Development and significance of RAPD-SCAR markers for Litchi chinensis Sonn. variety authentication by improved RAPD amplification and molecular cloning. Electronic Journal of Biotechnology. 18(1): 35-39. https://doi.org/10.1016/j.ejbt.2014.11.004. Cite Score: 5.6; Journal Quartile: Q3; ISI Impact Factor: 2.3

Tania M, Khan MA (equal contribution), Fu J (2014). Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumor Biology. 35(8): 7335-7342. https://doi.org/10.1007/s13277-014-2163-y. Cite Score: 5.4; Journal Quartile: Q2; ISI Impact Factor: 3.65 (IF of 2017, then dropped)

Mei Z, Khan MA, Zeng W, Fu J (2014). DNA fingerprints of living fossil Ginkgo biloba by using ISSR and improved RAPD analysis. Biochemical Systematics and Ecology. 57: 332-337. https://doi.org/10.1016/j.bse.2014.09.007. Cite Score: 3.0; Journal Quartile: Q3; ISI Impact Factor: 1.4

Tania M, Khan MA, Xia K (2014). Recent advances in animal model experimentation in autism research. Acta Neuropsychiatrica. 26(5): 264-271. https://doi.org/10.1017/neu.2013.58. Cite Score: 8.5; Journal Quartile: Q2; ISI Impact Factor: 2.6

Fatima N, Rahman MM, Khan MA*, Fu J (2014). A review on Ipomoea carnea: pharmacology, toxicology and phytochemistry. Journal of Complementary and Integrative Medicine. 11(2): 55-62. https://doi.org/10.1515/jcim-2013-0046. Cite Score: 3.1; Journal Quartile: Q2

Khan MA, Chen HC, Zhang D, Fu J (2013). Twist: A Molecular Target in Cancer Therapeutics. Tumor Biology. 34(5): 2497-2506. https://doi.org/10.1007/s13277-013-1002-x. Cite Score: 5.4; Journal Quartile: Q2; ISI Impact Factor: 3.65 (IF of 2017, then dropped)

Khan MA, Chen HC, Wan XX, Tania M, Xu A, Chen FZ, Zhang DZ (2013). Regulatory Effects of Resveratrol on Antioxidant Enzymes: A Mechanism of Growth Inhibition and Apoptosis Induction in Cancer Cells. Molecules and Cells. 35(3): 219-225. https://doi.org/10.1007/s10059-013-2259-z. Cite Score: 6.6; Journal Quartile: Q1; ISI Impact Factor: 3.7

Fu J, Yang L, Khan MA, Mei Z (2013). Genetic characterization and authentication of Lonicera japonica Thunb. by using improved RAPD analysis. Molecular Biology Reports. 40(10): 5993-5999. https://doi.org/10.1007/s11033-013-2703-3. Cite Score: 5.0; Journal Quartile: Q2; ISI Impact Factor: 2.6

Wan XX, Chen H, Khan MA, Xu AH, Yang FL, Zhang YY, Zhang D. ISG15 Inhibits IFN-α Resistant Liver Cancer Cell Growth. BioMed Research International. 2013; 2013: 570909. https://doi.org/10.1155/2013/570909. Cite Score: 6.7; Journal Quartile: Q2; ISI Impact Factor: 3.2 (IF of 2022, then dropped)

Huang FM, Chen HC, Khan MA, Yang FL, Wan XX, Xu AH, Ou-yang FD, Zhang DZ (2013). CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from Central South China. Medical Oncology. 30(2): 521. https://doi.org/10.1007/s12032-013-0521-z. Cite Score: 4.2; Journal Quartile: Q2; ISI Impact Factor: 2.8

Khan MA*, Tania M, Liu R, Rahman MM (2013). Hericium erinaceus: an edible mushroom with medicinal values. Journal of Complementary and Integrative Medicine. 10(1): 253-258. https://doi.org/10.1515/jcim-2013-0001. Cite Score: 3.1; Journal Quartile: Q2

Rahman MM, Khan MA* (2013). Anti-cancer potential of South Asian plants. Natural Products and Bioprospecting. 3(3): 74-88. https://doi.org/10.1007/s13659-013-0027-6. Cite Score: 8.3; Journal Quartile: Q1; ISI Impact Factor: 4.8

Khan MA*, Tania M (2012). Nutritional and Medicinal Importance of Pleurotus mushrooms: An Overview. Food Reviews international. 28(3): 313-329. https://doi.org/10.1080/87559129.2011.637267. Cite Score: 11.5; Journal Quartile: Q1; ISI Impact Factor: 5.3

Liu J, Chen HC, Rao ZZ, Khan MA, Wan XX, Xu AH, Zhang N, Zhang D (2011). Identification of heptapeptides interacting with IFN-α-sensitive CML cells. Expert Opinion on Investigational Drugs. 20(12): 1583-1589. https://doi.org/10.1517/13543784.2011.632407. Cite Score: 10.0; Journal Quartile: Q1; ISI Impact Factor: 4.9

Chen HC, Chen HJ, Khan MA, Rao ZZ, Wan XX, Tan B, Zhang DZ (2011). Genetic Mutations of p53 and k-ras in Gastric Carcinoma Patients from Hunan, China. Tumor Biology. 32(2): 367-373. https://doi.org/10.1007/s13277-010-0129-2. Cite Score: 5.4; Journal Quartile: Q2; ISI Impact Factor: 3.65 (IF of 2017, then dropped)

Luo YP, Chen HC, Khan MA, Chen FZ, Wan XX, Tan B, Ou-Yang FD, Zhang DZ (2011). Genetic polymorphisms of metabolic enzymes- CYP1A1, CYP2D6, GSTM1 and GSTT1, and gastric carcinoma susceptibility. Tumor Biology. 32(1): 215-222. https://doi.org/10.1007/s13277-010-0115-8. Cite Score: 5.4; Journal Quartile: Q2; ISI Impact Factor: 3.65 (IF of 2017, then dropped)

Khalil MI, Hoque MM, BasuniaMA, Alam N, Khan MA* (2011). Production of Cellulase by Pleurotus ostreatus and Pleurotus sajor-caju in Solid State Fermentation of Lignocellulosic Biomass. Turkish Journal of Agriculture and Forestry. 35(4): 333-341. https://doi.org/10.3906/tar-1002-684. Cite Score: 4.2; Journal Quartile: Q2; ISI Impact Factor: 3.0

Tania M, Khan MA, Zhang H, Li J, Song Y (2010). Autotaxin: a protein with two faces. Biochemical and Biophysical Research Communications. 401(4): 493-497. https://doi.org/10.1016/j.bbrc.2010.09.114. Cite Score: 6.1; Journal Quartile: Q1; ISI Impact Factor: 2.5

Khan MA, Tania M, Zhang DZ, Chen HC (2010). Antioxidant Enzymes and Cancer. Chinese Journal of Cancer Research. 22(2): 87-92. https://doi.org/10.1007/s11670-010-0087-7. Journal Quartile: Q2; ISI Impact Factor: 7.0

Tania M, Khan MA, Song Y (2010). Association of Lipid Metabolism with Ovarian Cancer. Current Oncology. 17(5): 6-11. https://doi.org/10.3747/co.v17i5.668. Cite Score: 3.3; Journal Quartile: Q2; ISI Impact Factor: 2.8

B. Book/Book chapters:

Junaid M, Akter Y, Afrose SS, Tania M, Khan MA* (2020). Apoptotic cell death: important cellular process as chemotherapeutic target (chapter 4). In: Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models (Editor: Tuli HS). Springer. PP: 65-88. ISBN: 978-981-15-7585-3/ 978-981-15-7586-0.

Zhou J, Chen S, Khan MA, Xiao T, Tania M, Khan MS, Fu J (2020). Epigenetics in Triple-Negative Breast Cancer (chapter 4). In: Triple-negative Breast Cancer (Editor: Deng X, Tang F, Rosol TJ). World Scientific. PP: 71-105. ISBN: 978-981-3277-75-5/ 978-981-3277077-9.

C. Selected Conference Papers: 

Khan MA, Zheng M, Fu J (2019). Epigenetic modification of oncogenes or tumor suppressor genes by thymoquinone in triple negative breast cancer. Proceedings of Annual meeting of American Association of Cancer Research; March 29- April 04, at Atlanta, GA, USA (Abstract No. 3834). Published in CANCER RESEARCH 2019; 79 (13suppl): 3834.

Fu J, Wei C, Cheng J, Khan MA, Yang L, Zou H (2018). Cordycepin inhibits breast cancer migration and invasion by targeting epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs). Proceedings of Annual meeting of American Association of Cancer Research; April 14-18, at Chicago, IL, USA (Abstract No. 2039). Published in CANCER RESEARCH 2018; 78 (13suppl): 2039.

Khan MA, Wu, F, Ying R, Gobel V, Zhang H (2016). RNAi-based screens identify tube morephogenesis genes in the C. elegans spermatheca. The Allied Genetics Conference 2016; July 13-17, 2016 at Orlando, Florida, USA (Abstract No. W4109A)

Khan MA, Tania M, Wei C, Fu J (2015). Relationship between transcription factor TWIST1 and microRNA34a in metastatic cancer cells. Proceedings of Annual meeting of American Association of Cancer Research; April 18-22, 2015 at Philadelphia, PA, USA (Abstract No. 1978). Published in CANCER RESEARCH 2015; 75 (15suppl): 1978.

Khan MA, Yang M, Wei C, Gan L, Fu J (2014). Thymoquinone downregulates n-cadherin, twist and snail expression and inhibits migration and invasion in cancer cells. Proceedings of Annual meeting of American Association of Cancer Research; April 05-09, 2014 at San Diego, USA (Abstract No. 5009). Published in CANCER RESEARCH 2014; 74(19suppl): 5009.

Khan MA, Wan XX, Xu A, Zhang DZ, Chen HC (2012). Resveratrol modifies the activity and expression of antioxidant enzymes in somatic cancer cells. Proceedings of Annual meeting of American Association of Cancer Research; March 31- April 04, 2012 at Chicago, USA (Abstract no. 1997) Published in CANCER RESEARCH 2012; 72(8suppl):1997